Immune Classification of Hidradenitis Suppurativa: Modulation by Secukinumab

被引：4
|
作者：
Stergianou, Dimitra [1 ]
Micha, Styliani [1 ]
Tzanetakou, Vassiliki [1 ]
Kanni, Theodora [1 ]
Gkavogianni, Theologia [1 ]
Katoulis, Alexandros [2 ]
Giamarellos-Bourboulis, Evangelos J. [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Dermatol & Venereol 2, Athens, Greece
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 12期
关键词：
D O I：
10.1016/j.jid.2023.04.028
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：2518 / +
页数：6
相关论文
共 50 条
  • [21] Hidradenitis suppurativa: the role of immune dysregulation
    Kelly, Genevieve
    Sweeney, Cheryl M.
    Tobin, Anne-Marie
    Kirby, Brian
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (10) : 1186 - 1196
  • [22] Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa
    Tas-Aygar, Gamze
    Gonul, Muzeyyen
    Ozcan, Ibrahim
    Ayli, Mehmet Deniz
    Ertoy-Baydar, Dilek
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [23] Secukinumab-induced paradoxical hidradenitis suppurativa successfully treated with adalimumab
    Babino, Graziella
    D'Ambra, Ilenia
    Fulgione, Elisabetta
    Alfano, Roberto
    Verolino, Pasquale
    Argenziano, Giuseppe
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (02) : E79 - E80
  • [24] Effectiveness and safety of secukinumab in patients with hidradenitis suppurativa: Our clinical experience
    Melgosa Ramos, Francisco Javier
    Garcia-Ruiz, Ramon
    Sanchez-Martinez, Eva M.
    Gegundez-Hernandez, Hector
    Diaz Corpas, Tania
    Perez Garcia, Pilar
    Ferrando Roca, Francisco Jose
    Zayas Gavila, Ana Isabel
    Mateu-Puchades, Almudena
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 79 - 80
  • [25] Local immune imbalances in hidradenitis suppurativa skin
    Emelianov, V. E.
    Taungjaruwinai, W. M.
    Bechara, F.
    Glaeser, R.
    Schroeder, J. M.
    Paus, R.
    Meyer, K. C.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 223 - 223
  • [26] VISTA immune checkpoint is dysregulated in hidradenitis suppurativa
    Kidacki, M.
    Cho, C.
    Lopez-Giraldez, F.
    Jaiswal, A.
    Breidbart, R.
    Damsky, W.
    Vesely, M. D.
    Chen, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S141 - S141
  • [27] Assessment tools and phenotype classification for hidradenitis suppurativa
    Koerts, Nicole D. K.
    Bouwman, Klasiena
    Prens, Lisette M.
    Horvath, Barbara
    CLINICS IN DERMATOLOGY, 2023, 41 (05) : 601 - 610
  • [28] Interleukin-17 inhibitor secukinumab in refractory hidradenitis suppurativa: A case report
    Pandey, Kritika
    Sekhri, Rajiv
    Sekhri, Vinoo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB156 - AB156
  • [29] The preclinical discovery and development of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
    Knecht-Gurwin, Klaudia
    Matusiak, Lukasz
    Szepietowski, Jacek C.
    EXPERT OPINION ON DRUG DISCOVERY, 2025,
  • [30] Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever
    Enginar, Ayse Unal
    Gundogdu, Mustafa
    MODERN RHEUMATOLOGY CASE REPORTS, 2022, 6 (01) : 19 - 21
12345